G5-7

CAT: 0804-HY-115452-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-115452-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
G5-7, an orally active and allosteric JAK2 inhibitor, selectively inhibits JAK2 mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3 by binding to JAK2. G5-7 induces cell cycle arrest, apoptosis and possesses antiangiogenic effect. G5-7 has the potential for glioma study[1].
CAS Number
[939681-36-4]
Product Name Alternative
ZK-76613
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Apoptosis; JAK
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/g5-7.html
Concentration
10mM
Purity
99.55
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(N1C/C(C(/C(C1)=C\C2=CC=CC=C2F)=O)=C/C3=CC=CC=C3F)OCC
Molecular Formula
C22H19F2NO3
Molecular Weight
383.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Kunyan He, et al. Blockade of glioma proliferation through allosteric inhibition of JAK2. Sci Signal. 2013 Jul 9;6 (283) :ra55.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK2

Related Products

CatalogName
HY-100996-0110074-G5
HY-100996R10074-G5 (Standard)
HY-100738-01Ubiquitin Isopeptidase Inhibitor I, G5
HY-100738RUbiquitin Isopeptidase Inhibitor I, G5 (Standard)
HY-164098JWZ-7-7-Neg1
HY-152793-017-Cyano-7-deazaguanosine
HY-149582Aβ-IN-7
HY-117136AN-7
HY-W001494-017-Methoxy-7-oxoheptanoic acid
HY-1321477-Deaza-7-propargylamino-ddATP

Alternative Products

CatalogName
BA3065-5.1G5-7
MBS3606718-01JAK2 inhibitor G5-7
6776/50G5
MBS3842144-0110074-G5
TBZ1303Euglobal G5
sc-100685CES2 (G5)

Popular Products